受强制性开放获取政策约束的文章 - Shweta S. Chavan了解详情
无法在其他位置公开访问的文章：3 篇
Genome-wide scan identifies variant in 2q12. 3 associated with risk for multiple myeloma
SW Erickson, VR Raj, OW Stephens, I Dhakal, SS Chavan, ...
Blood, The Journal of the American Society of Hematology 124 (12), 2001-2003, 2014
强制性开放获取政策： US National Institutes of Health
PD12-12 PATIENT MATCHED GENOMIC ANALYSIS OF HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER SPECIMENS PRE-AND POST-BCG IMMUNOTHERAPY
T Clinton, J Lavery, N Almassi, S Chavan, S Dason, V McPherson, ...
Journal of Urology 203, e263-e264, 2020
强制性开放获取政策： US National Institutes of Health
PD42-06 DEFINING THE GENETIC EVOLUTION OF EPIGENETIC ALTERATIONS IN BLADDER CANCER
T Clinton, H Wise, N Almassi, S Chavan, W Hu, S Dason, E Pietzak, ...
Journal of Urology 203, e829, 2020
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：39 篇
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
L Rasche, SS Chavan, OW Stephens, PH Patel, R Tytarenko, C Ashby, ...
Nature communications 8 (1), 268, 2017
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Tumour lineage shapes BRCA-mediated phenotypes
P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ...
Nature 571 (7766), 576-579, 2019
强制性开放获取政策： US National Institutes of Health
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
YY Janjigian, SB Maron, WK Chatila, B Millang, SS Chavan, C Alterman, ...
The Lancet Oncology 21 (6), 821-831, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
N Weinhold, C Ashby, L Rasche, SS Chavan, C Stein, OW Stephens, ...
Blood, The Journal of the American Society of Hematology 128 (13), 1735-1744, 2016
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
P Jonsson, AL Lin, RJ Young, NM DiStefano, DM Hyman, BT Li, ...
Clinical Cancer Research 25 (18), 5537-5547, 2019
强制性开放获取政策： US National Institutes of Health
Inhibiting MEK in MAPK pathway-activated myeloma
CJ Heuck, Y Jethava, R Khan, F Van Rhee, M Zangari, S Chavan, ...
Leukemia 30 (4), 976-980, 2016
强制性开放获取政策： US National Institutes of Health
Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ...
Cancer discovery 11 (12), 3028-3047, 2021
强制性开放获取政策： US National Institutes of Health
The spectrum and clinical impact of epigenetic modifier mutations in myeloma
C Pawlyn, MF Kaiser, C Heuck, L Melchor, CP Wardell, A Murison, ...
Clinical cancer research 22 (23), 5783-5794, 2016
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, Wellcome Trust
Genomic landscape of uterine sarcomas defined through prospective clinical sequencing
ML Hensley, SS Chavan, DB Solit, R Murali, R Soslow, S Chiang, ...
Clinical Cancer Research 26 (14), 3881-3888, 2020
强制性开放获取政策： US National Institutes of Health
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification
OW Stephens, Q Zhang, P Qu, Y Zhou, S Chavan, E Tian, DR Williams, ...
Blood, The Journal of the American Society of Hematology 119 (2), 503-512, 2012
强制性开放获取政策： US National Institutes of Health
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
SS Chavan, J He, R Tytarenko, S Deshpande, P Patel, M Bailey, CK Stein, ...
Blood cancer journal 7 (2), e535-e535, 2017
强制性开放获取政策： US National Institutes of Health
The context-specific role of germline pathogenicity in tumorigenesis
P Srinivasan, C Bandlamudi, P Jonsson, Y Kemel, SS Chavan, ...
Nature genetics 53 (11), 1577-1585, 2021
强制性开放获取政策： US National Institutes of Health
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
H Taniguchi, R Caeser, SS Chavan, YA Zhan, A Chow, P Manoj, F Uddin, ...
Cell reports 39 (7), 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
A Chow, FZ Uddin, M Liu, A Dobrin, BY Nabet, L Mangarin, Y Lavin, ...
Immunity 56 (1), 93-106. e6, 2023
强制性开放获取政策： US National Institutes of Health
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ...
Journal of Hematology & Oncology 14, 1-19, 2021
强制性开放获取政策： US National Institutes of Health
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
J Taylor, MTA Donoghue, C Ho, K Petrova-Drus, HA Al-Ahmadie, SA Funt, ...
The Journal of clinical investigation 130 (12), 6668-6676, 2020
强制性开放获取政策： US National Institutes of Health, Robert Wood Johnson Foundation
Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
R Caeser, JV Egger, S Chavan, ND Socci, CB Jones, FE Kombak, ...
Nature Communications 13 (1), 2144, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定